As the RNA solutions leader for academic research and therapeutic development, Eclipsebio is dedicated to sponsoring graduate student education and events that bring together world experts in RNA biology. Eclipsebio is proud to announce their sponsorship of RNA UK 2024 which is in Windermere, UK from January 25th to the 28th. This biannual non-profit meeting that brings experts from across the UK together to discuss the latest advances in:
- Transcription
- Translation
- RNA structure
- RNA modifications
- The role of RNA in diseases
The meeting will be an exciting exchange of ideas and we are looking forward to learning the latest in RNA discoveries.
If you are interested in making your own discoveries with our comprehensive solutions for therapeutic development or academic research, contact our team of RNA experts today.
Latest news
Eclipsebio Launches eVERSE™, a First-of-Its-Kind Comprehensive Portfolio of RNA-Focused Datasets for AI Model Success
Eclipse Bioinnovations, Inc. (Eclipsebio), the leading partner for RNA-based and RNA-targeting therapeutic development, today announced the launch of its eVERSE™ portfolio of AI-ready datasets. eVERSE is a first-in-class collection of datasets generated from all key aspects of RNA biology that inform therapeutic development from target discovery to drug design.
2025 Data Catalyst Award Announcement
To support researchers as they generate RNA datasets, Eclipsebio is proud to announce the 2025 Data Catalyst Award. Winners of the award will obtain matching funds to cover the cost of generating their control datasets.
Decoding Microproteins Across Evolution and Disease
Eclipsebio is proud to announce their sponsorship of the 2025 Gordon Research Conference on Decoding Microproteins Across Evolution and Disease in Barcelona.
Eclipsebio Expands eMERGE™ Platform with eSENSE dsRNA™ for dsRNA Quantification and Localization
SAN DIEGO, September 3, 2024 — Eclipse Bioinnovations, Inc. (Eclipsebio), the leader in developing precision solutions for RNA-based and RNA-targeting therapeutics, today announced the launch of its eSENSE dsRNA™ assay. eSENSE dsRNA is a next-generation sequencing method for the robust quantification, localization, and optimization of double-stranded RNA (dsRNA) contaminants in RNA-based vaccines and therapeutics. “By […]